Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins

By sjmartinez • October 18, 2024

Seabrook LJ, Franco CN, Loy CA, Osman J, Fredlender C, Zimak J, Campos M, Nguyen ST, Watson RL, Levine SR, Khalil MF, Sumigray K, Trader DJ, Albrecht LV. Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins. Nat Chem Biol. 2024 Oct 16. doi: 10.1038/s41589-024-01741-y. Epub ahead of print. PMID: 39414979.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E,[...]

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt E, Eibl G. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Ther. 2026 Jan 3;11(1):6. doi: 10.1038/s41392-025-02499-y. PMID: 41484057; PMCID: PMC12764932.

Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease

Chang A, Shahrvini B, Oh J, Prajapati DP, Baniqued M, Harmon R, Greb AC, Bonthala N, Sauk JS, Shin A, Chang L, Limketkai BN. Increased[...]